TrialBMC geriatrics2013

Evaluating the cognitive effects of donepezil 23 mg/d in moderate and severe Alzheimer's disease: analysis of effects of baseline features on treatment response.

Marwan Sabbagh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.